Literature DB >> 1165473

Requirement for vasoactive amines for production of delayed-type hypersensitvity skin reactions.

R K Gershon, P W Askenase, M D Gershon.   

Abstract

The skin sites of the mouse where delayed-type hypersensitivity (DTH) reactions are most easily elicited (foot pads and ears) are particularly rich in 5-hydroxytryptamine (5-HT)-containing mast cells. Since mice are deficient in circulating basophils, which play a role in at least some DTH reactions, we investigated the possibility that the mast cells were playing an important role in the evolution of the skin reactions of DTH in mice. We found that reserpine, a drug which depletes mast cells of 5-HT, abolished the ability of the mouse to make DTH reactions in the skin. The suppressive effect of reserpine could be partially blocked by monoamine oxidase inhibitors which prevent the degradation of 5-HT in the cytosol of the mast cell. Spleen cells of immune, reserpine-treated mice transferred DTH reactions to nonimmune mice normally, indicating that the reserpine treatment did not affect immune T cells. DTH reactions could not be transferred into reserpine-treated mice. We suggest that T cells are continually emigrating from the blood, through postcapillary venule endothelium, by a mechanism which does not depend on vasoactive amines. If they are appropriately immune and meet the homologous antigen in the tissue, they induce mast cells to release vasoactive amines which cause postcapillary venule endothelial cells to separate, allowing the egress from the blood of cells which ordinarily do not recirculate. The secondarily arriving vasoactive amine-dependent cells are responsible for the micro- and macroscopic lesions of DTH reactions. Chemotactic factors may also be involved in bringing cells to the DTH reaction sites but we propose that T-cell regulation of vasoactive amine-containing cells allows the effector cells to pass through the endothelial gates after they are called.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1165473      PMCID: PMC2189924          DOI: 10.1084/jem.142.3.732

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  45 in total

1.  Role of nonimmunized macrophages in the rejection of an allotransplanted lymphoma.

Authors:  K Nomoto; R K Gershon; B H Waksman
Journal:  J Natl Cancer Inst       Date:  1970-03       Impact factor: 13.506

2.  The induction of exacerbations of allergic meningoencephalomyelitis.

Authors:  L H BOGDANOVE; G CLARK
Journal:  J Neuropathol Exp Neurol       Date:  1957-01       Impact factor: 3.685

3.  Allergy in experimental mouse tuberculosis.

Authors:  D F GRAY; P A JENNINGS
Journal:  Am Rev Tuberc       Date:  1955-08

4.  Delayed hypersensitivity: is the same population of thymus-derived cells responsible for cellular immunity reactions and the carrier effect?

Authors:  J Kettman
Journal:  Immunol Commun       Date:  1972

Review 5.  Immunologic mechanisms of platelet damage.

Authors:  A G Osler; R P Siraganian
Journal:  Prog Allergy       Date:  1972

6.  Infection in patients on maintenance haemodialysis.

Authors:  R A Kaslow; S R Zellner
Journal:  Lancet       Date:  1972-07-15       Impact factor: 79.321

7.  Localization and binding of reserpine in the membrane of adrenomedullary amine storage granules.

Authors:  A Giachetti; R A Hollenbeck; P A Shore
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

8.  Ionic mechanisms and receptor properties underlying the responses of molluscan neurones to 5-hydroxytryptamine.

Authors:  H M Gerschenfeld; D Paupardin-Tritsch
Journal:  J Physiol       Date:  1974-12       Impact factor: 5.182

9.  Radioisotopic studies of the binding, exchange, and distribution of 5-hydroxytryptamine synthesized from its radioactive precursor.

Authors:  M D Gershon; L L Ross
Journal:  J Physiol       Date:  1966-10       Impact factor: 5.182

10.  Location of sites of 5-hydroxytryptamine storage and metabolism by radioautography.

Authors:  M D Gershon; L L Ross
Journal:  J Physiol       Date:  1966-10       Impact factor: 5.182

View more
  53 in total

1.  Antigen-specific mast cell degranulation in contact sensitivity to picryl chloride. An early event.

Authors:  W R Thomas; N Vardinon; M C Watkins; G L Asherson
Journal:  Immunology       Date:  1980-03       Impact factor: 7.397

2.  Localization of leucocytes in sites of delayed-type hypersensitivity and in lymph nodes: dependence on vasoactive amines.

Authors:  P W Askenase; C M Metzler; R K Gershon
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

3.  Histamine 2 receptor-mediated immunomodulation in the mouse. I. Immunomodulation by the H2 agonist tolazoline.

Authors:  H Van Dijk; M Rapis; H E Jacobse-Geels; J M Willers
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

4.  II. Tumor growth at sites of inflammation induced by mitogens in mice.

Authors:  M Nelson; D S Nelson
Journal:  Am J Pathol       Date:  1981-08       Impact factor: 4.307

Review 5.  Basophils in human disease.

Authors:  E B Mitchell; P W Askenase
Journal:  Clin Rev Allergy       Date:  1983-09

6.  Experimental allergic orchitis in mice. II. Association of disease susceptibility with the locus controlling Bordetella pertussis-induced sensitivity to histamine.

Authors:  C Teuscher
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

7.  Pharmacological studies on lymphocytes: 2. Effects of indole derivatives and their antagonists on the lymphocyte migration.

Authors:  I Paegelow; P Lange
Journal:  Agents Actions       Date:  1984-10

8.  Suppressor effects of histamine on SK/SD delayed hypersensitivity reactions in man and on E-rosette-forming cells.

Authors:  U Ambanelli; G F Ferraccioli; P Mangenelli; G L Vanona
Journal:  Agents Actions       Date:  1979-12

Review 9.  Enteric Neuronal Regulation of Intestinal Inflammation.

Authors:  Kara Gross Margolis; Michael D Gershon
Journal:  Trends Neurosci       Date:  2016-07-20       Impact factor: 13.837

10.  Transfer of an antigen-specific immediate hypersensitivity-like reaction with an antigen-binding factor produced by T cells.

Authors:  W Ptak; P W Askenase; R W Rosenstein; R K Gershon
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.